Intracoronary brachytherapy, a promising treatment option for diabetic patients: Results from a European multicenter registry (RENO)

Doxorubicin-paclitaxel : A safe regimen

Doxorubicin-paclitaxel : A safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European Organization for Research and Treatment of Cancer multicenter trial

✍ Laura Biganzoli; Tanja Cufer; Peter Bruning; Robert E. Coleman; Luc Duchateau; B 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB 👁 2 views

## Abstract ## BACKGROUND The potential cardiotoxicy of the doxorubicin‐paclitaxel regimen, when paclitaxel is given shortly after the end of the anthracycline infusion, is an issue of concern, as suggested by small single institution Phase II studies. ## METHODS In a large multicenter Phase III